Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy

<p>Differential expression analysis gene list of FACS sorted CD16+ compared to CD16- macrophages from human melanoma dissociates.</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Hansol Lee (15054787) (author)
Diğer Yazarlar:	Angela L. Ferguson (15050051) (author), Camelia Quek (15049218) (author), Ismael A. Vergara (15054784) (author), Ines Pires daSilva (15056800) (author), Ruth Allen (15056803) (author), Tuba Nur Gide (15056806) (author), Jordan W. Conway (15056809) (author), Lambros T. Koufariotis (15056812) (author), Nicholas K. Hayward (14956488) (author), Nicola Waddell (12694196) (author), Matteo S. Carlino (15056815) (author), Alexander M. Menzies (11420816) (author), Robyn P.M. Saw (15056818) (author), Elena Shklovskaya (15056821) (author), Helen Rizos (15008946) (author), Serigne Lo (15056824) (author), Richard A. Scolyer (10778711) (author), Georgina V. Long (11420813) (author), Umaimainthan Palendira (15050084) (author), James S. Wilmott (15008931) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Cancer Detection and Diagnosis Immuno-oncology Biomarkers Prognostic biomarkers Immunology Immune responses to cancer Innate immunity Tumor-associated macrophages Immunotherapy Biomarkers for immunotherapy Checkpoint blockade Combination immunotherapy Skin Cancers Melanoma
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller